Skip to main content
Harbin Pharmaceutical Group Co.,Ltd. logo

Harbin Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings

Ticker · 600664 ISIN · CNE0000009T3 LEI · 300300G0L086UJ23MI26 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,827 across all filing types
Latest filing 2015-11-16 Declaration of Voting R…
Country CN China
Listing Shanghai Stock Exchange 600664

About Harbin Pharmaceutical Group Co.,Ltd.

https://www.hayao.com/

Harbin Pharmaceutical Group Co., Ltd. specializes in the research, development, manufacture, and distribution of a diverse range of pharmaceutical and healthcare products. The company's portfolio includes antibiotics, over-the-counter (OTC) medicines, health supplements, traditional Chinese medicines, and animal health products. It operates through several specialized subsidiaries and maintains a significant presence in the production of penicillins and cephalosporins. A key strategic focus involves the health and nutrition sector, bolstered by the acquisition of global nutrition brand GNC. The company leverages large-scale manufacturing capabilities and an extensive distribution network to serve both domestic and international markets. Its operations emphasize technological innovation and quality control across its integrated supply chain, from raw material production to finished dosage forms.

Recent filings

Filing Released Lang Actions
2015年第三次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal announcement of the resolutions passed at the 2015 third extraordinary shareholders' meeting of 哈药集团股份有限公司. It includes details about the meeting date, attendance, voting results on various proposals, and legal witness statements. The content focuses on the outcomes of shareholder votes rather than the meeting materials or presentations. The document length is short (1700 characters), and it is clearly a resolution announcement rather than a full report or presentation. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2015-11-16 Chinese
2015年第三次临时股东大会之法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the procedural legality and validity of a company's 2015 third extraordinary general meeting (临时股东大会). It details the convening, attendance, voting procedures, and results of the meeting, confirming compliance with relevant laws and company articles. The document does not contain financial statements or performance data, nor is it a report of financial results or management discussion. It is a legal opinion related to a shareholder meeting, specifically focusing on the voting results and procedural compliance. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting results and validates the meeting procedures. The document length is 4080 characters, which is consistent with a detailed legal opinion rather than a brief announcement or a full annual/interim report. Therefore, the appropriate classification is DVA with high confidence.
2015-11-16 Chinese
2015年中期利润分配实施公告
Notice of Dividend Amount Classification · 100% confidence The document is titled as a "2015 Mid-Year Profit Distribution Implementation Announcement" from 哈药集团股份有限公司. It details the dividend amount per share, tax treatment, record dates, and payment dates. It references the shareholders' meeting that approved the dividend distribution plan and provides detailed instructions on dividend payment and tax withholding. The document is an announcement about the dividend distribution, not a full financial report or earnings release. It fits the definition of a Notice of Dividend Amount (DIV), which announces dividend amounts, payment dates, and details for shareholders.
2015-11-05 Chinese
2015年第三次临时股东大会会议材料
AGM Information Classification · 95% confidence The document is titled as materials for the 2015 third extraordinary shareholders meeting of Harbin Pharmaceutical Group Co., Ltd. It includes meeting agenda, voting procedures, proposals for board-related matters such as the establishment of an external director allowance system and the replacement of a supervisor, and candidate resumes. The content is clearly related to the preparation and materials for a shareholders meeting rather than the meeting minutes or voting results. The document length is 3155 characters, which is relatively short and consistent with meeting materials rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or Extraordinary General Meeting.
2015-11-05 Chinese
独立董事关于公司外部董事津贴制度的独立意见
Remuneration Information Classification · 90% confidence The document is an independent opinion from the independent directors of 哈药集团股份有限公司 regarding the company's external director allowance system. It references company law and articles of association, and it is an opinion supporting a proposal to be submitted to the shareholders' meeting. The document is short (475 characters) and does not contain financial data, audit information, or detailed management discussion. It is related to governance and remuneration but is specifically an independent opinion on a remuneration proposal, not a full remuneration report. Given the nature of the document as an independent opinion on a director remuneration proposal, it fits best under Remuneration Information (DEF 14A), which covers reports detailing compensation for top executives and directors or related remuneration matters.
2015-10-30 Chinese
七届十一次董事会决议公告
Board/Management Information Classification · 95% confidence The document is a board resolution announcement from 哈药集团股份有限公司 (Harbin Pharmaceutical Group Co., Ltd.) dated October 31, 2015. It details the decisions made at the 11th meeting of the 7th Board of Directors, including approval of the 2015 third quarter report, adoption of an external director allowance system, and the scheduling of a third extraordinary shareholders meeting. The document is a formal announcement of board decisions rather than the full quarterly report itself. It references the full 2015 third quarter report being available on the Shanghai Stock Exchange website, indicating this document is not the report but a board meeting resolution announcement. Therefore, it fits best under Board/Management Information (MANG) as it concerns board meeting resolutions and governance decisions. The document length is short (1059 characters), consistent with an announcement rather than a full report.
2015-10-30 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.